BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2657229)

  • 1. Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors.
    Wörmann B; Gesner TG; Mufson RA; LeBien TW
    Leukemia; 1989 Jun; 3(6):399-404. PubMed ID: 2657229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors.
    Pandrau D; Saeland S; Duvert V; Durand I; Manel AM; Zabot MT; Philippe N; Banchereau J
    J Clin Invest; 1992 Nov; 90(5):1697-706. PubMed ID: 1385474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1.
    Uckun FM; Myers DE; Fauci AS; Chandan-Langlie M; Ambrus JL
    Blood; 1989 Aug; 74(2):761-76. PubMed ID: 2526668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemic B-cell precursors express functional receptors for human interleukin-3.
    Uckun FM; Gesner TG; Song CW; Myers DE; Mufson A
    Blood; 1989 Feb; 73(2):533-42. PubMed ID: 2644978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias.
    Wörmann B; Anderson JM; Ling ZD; LeBien TW
    Leukemia; 1987 Sep; 1(9):660-6. PubMed ID: 3118114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of early B lymphopoiesis by interleukin-3.
    Ball TC; Hirayama F; Ogawa M
    Exp Hematol; 1996 Aug; 24(10):1225-31. PubMed ID: 8765498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence of normal and neoplastic human B cell precursors to the bone marrow microenvironment.
    Ryan DH
    Blood Cells; 1993; 19(2):225-41; discussion 241-4. PubMed ID: 7906154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a leukemic cell model for studying human pre-B to B cell differentiation.
    Wörmann B; Anderson JM; Liberty JA; Gajl-Peczalska K; Brunning RD; Silberman TL; Arthur DC; LeBien TW
    J Immunol; 1989 Jan; 142(1):110-7. PubMed ID: 2642502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
    Petrucci MT; De Felice L; Ricciardi MR; Ariola C; Mascolo MG; Fenu S; Tafuri A
    Cytokines Mol Ther; 1996 Dec; 2(4):225-30. PubMed ID: 9384708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF.
    van Gils FC; Budel LM; Burger H; van Leen RW; Löwenberg B; Wagemaker G
    Exp Hematol; 1994 Mar; 22(3):248-55. PubMed ID: 7509288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effect of IL-7-enhanced CD19 expression on human B cell precursors.
    Wolf ML; Weng WK; Stieglbauer KT; Shah N; LeBien TW
    J Immunol; 1993 Jul; 151(1):138-48. PubMed ID: 7686930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Myers DE; Ledbetter JA; Swaim SE; Gajl-Peczalska KJ; Vallera DA
    J Immunol; 1988 Mar; 140(6):2103-11. PubMed ID: 3126241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal.
    Perri RT; Kay NE
    Leukemia; 1987 Feb; 1(2):127-30. PubMed ID: 3118104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking CD40 on human B cell precursors inhibits or enhances growth depending on the stage of development and the IL costimulus.
    Larson AW; LeBien TW
    J Immunol; 1994 Jul; 153(2):584-94. PubMed ID: 7517420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 4 inhibits the proliferation and promotes the maturation of human leukemic early B cells.
    Ouaaz F; Mentz F; Mossalayi MD; Schmitt C; Michel A; Debre P; Guillosson JJ; Merle-Beral H; Arock M
    Eur J Haematol; 1993 Nov; 51(5):276-81. PubMed ID: 8282088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
    Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
    Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell receptor gene rearrangements in B-precursor acute lymphoblastic leukemia correlate with age and the stage of B cell differentiation.
    Nuss R; Kitchingman G; Cross A; Zipf TF; Antoun GR; Bernstein I; Behm F; Pullen DJ; Crist W; Mirro J
    Leukemia; 1988 Nov; 2(11):722-7. PubMed ID: 2972889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
    Kasid A; Bell GI; Director EP
    J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
    Strauss LC; Welsh SB; Civin CI
    Exp Hematol; 1991 Sep; 19(8):734-41. PubMed ID: 1714400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.